Hispanic Healthbridge advises pharma medical affairs teams, research organizations, and patient advocacy foundations, bringing a nationally recognized track record in Hispanic patient outreach to clinical trial recruitment, patient engagement, and FDA diversity action plans across multiple disease areas.
Hispanic Healthbridge is the independent advisory practice of Daniel Hernandez, MD, grounded in a nationally recognized body of Hispanic patient outreach work across multiple disease areas and built for pharma, research organizations, and patient advocacy foundations.
We help organizations turn outreach into outcomes by aligning program design with community trust, digital behavior, language preferences, and the patient experience across research, education, and long-term support.
The methodology (community trust architecture, mobile-first delivery, family-inclusive design, and bilingual program development) is not disease-specific. Hispanic patients managing rheumatoid arthritis, a cancer diagnosis, a neurological condition, or a cardiometabolic disease face the same structural barriers to care and research participation: language, familismo, mistrust of medical institutions, and health misinformation traveling through family networks. HOPE-CAPE RA demonstrated the model. The model transfers across therapeutic areas.
Program strategy, patient recruitment, advisory engagement, trusted provider partnerships, and support services built specifically for Hispanic and underserved patient populations.
Each program below was designed and executed under Dr. Hernandez's leadership, spanning disease-specific education, insurance navigation, health equity, and community-informed research engagement.
Culturally adapted Hispanic RA education and the first-ever RA grant in BMS Foundation history. Dr. Hernandez served as principal investigator.
Read the case studyA bilingual, cohort-specific RA campaign built for two distinct audiences: Spanish-speaking patients and their English-speaking family members, each with its own program, voice, and resources.
Read the case studyA two-year weekly WhatsApp support program for Hispanic RA patients that achieved 100% participant retention, led by trained promotores de salud and grounded in evidence-based clinical content.
Read the case studyThe first formally documented study of the unique education and support needs of Hispanic/Latinx RA patients, conducted with Hospital for Special Surgery and presented at ACR Convergence 2022.
Read the case studyRead our latest thinking on misinformation, mobile-first Hispanic engagement, and the kinds of outreach that help programs move from passive awareness to active participation.
Explore a new perspective on patient education, community-informed clinical trial recruitment, and outreach strategies that improve access for underserved Hispanic communities.
Read the articleWe shape programs that use trusted channels, community context, and plainspoken language to make outreach feel relevant and respectful.
Daniel Hernandez, MD, Founder
Dr. Hernandez built some of the most-cited work in Hispanic patient engagement across multiple disease areas, serving as principal investigator on HOPE-CAPE RA and the force behind a WhatsApp outreach platform recognized by Fierce 50.
Hispanic Healthbridge applies that body of work as an independent advisor for pharma medical affairs teams navigating FDA diversity action plans, research organizations closing Hispanic enrollment gaps, and patient advocacy foundations designing grant-worthy Hispanic programs.
Read the full storyNavigation services designed for Hispanic patients, in their language, on their devices, in their voice.
Supporting enrollment in clinical trials, insurance programs, and treatment pathways for underserved communities.
Equipping pharma and advocacy partners with the tools, frameworks, and expertise to design high-impact Hispanic outreach programs.
WhatsApp-powered and mobile-first outreach campaigns that dramatically improve patient response rates.
Every engagement is scoped to your program’s stage and your team’s needs. Most pharma medical affairs and research organization engagements fall into one of three models.
Scoped, time-limited advisory for teams in the planning phase. Includes FDA diversity action plan design and review, Hispanic enrollment framework development, and program strategy assessment. No ongoing commitment required.
Project-based engagement to design, develop, and prepare a complete Hispanic outreach program for launch, covering community landscape analysis and bilingual materials through site coordinator playbooks, promotor/promotora integration, and measurement framework.
Retained advisory relationship for pharma medical affairs teams that need sustained Hispanic outreach expertise across multiple programs, trial phases, or therapeutic areas. Dr. Hernandez functions as an embedded strategic partner for your medical affairs or clinical operations team.
Engagements are scoped individually. To discuss which model fits your team and timeline, get in touch.
Whether you lead a pharma medical affairs team, a patient advocacy foundation, or a research organization with Hispanic enrollment gaps, Dr. Hernandez can help you design outreach that earns trust and performs.